Phthalide-to-Phthalane Strategy for the Synthesis of Citalopram and Its Analogues
Synthesis · 12.11.2026
DOI: 10.1055/a-2991-3513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, online erschienen am 12.11.2026. Verfasst von Hamdi Sanaa und 3 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Gefördert von: University of tours, Ministère de l’Enseignement supérieur et de la Recherche.
Abstract (Originalsprache)
Citalopram is a widely prescribed racemic selective serotonin reuptake inhibitor (SSRI) and a privileged scaffold for the design analogues. We report new synthetic approaches to citalopram based on 3-arylphthalide. The first route, starting from an easily accessible 6-methoxyphthalide, was successfully elaborated up to a mesylate–citalopram precursor. The second, bromide-based route proved fully productive, delivering citalopram in six steps and 23% overall yield. This strategy was applied to prepare three original citalopram amino-analogues, highlighting the versatility of this synthetic pathway.
Förderung
- University of tours
- Ministère de l’Enseignement supérieur et de la Recherche
Zitieren
APA
Sanaa, H., Eddebbarh, E., Thibonnet, J., & Petrignet, J. (2026). Phthalide-to-Phthalane Strategy for the Synthesis of Citalopram and Its Analogues. Synthesis. https://doi.org/10.1055/a-2991-3513
Vancouver
Sanaa H, Eddebbarh E, Thibonnet J, Petrignet J. Phthalide-to-Phthalane Strategy for the Synthesis of Citalopram and Its Analogues. Synthesis. 2026. doi:10.1055/a-2991-3513
BibTeX
@article{Sanaa2026,
author = {Sanaa, Hamdi and Eddebbarh, Enzo and Thibonnet, Jérôme and Petrignet, Julien},
title = {Phthalide-to-Phthalane Strategy for the Synthesis of Citalopram and Its Analogues},
journal = {Synthesis},
year = {2026},
doi = {10.1055/a-2991-3513}
}
EUVIMED